Literature DB >> 99598

Enzyme induction in the uremic liver.

H W Leber, L Gleumes, G Schütterle.   

Abstract

Forty-five days after subtotal nephrectomy or sham-operation of male rats, microsomal enzymes were investigated in vitro. The activities (per milligram) of microsomal protein of two esterases and of two glucuronyltransferases were normal in the uremic rats. The mixed-function oxidation system had lower activities per milligram of protein than that in sham-operated controls. Due to a decrease of the microsomal protein content of the uremic liver, the activities of these enzymes were decreased when calculated for the whole liver. In contrast, the glucoronidation of phenolphthalein remained normal when related to the whole liver, due to an increased activity per mg of protein. Treatment with the plasticizer di-(2-ethylhexyl)-phthalate caused a significant increase of the liver wet weight, the microsomal protein content, and the activity per mg of protein for the demethylation of aminopyrine in subtotally nephrectomized rats but was without influence on the liver of sham-operated controls. It is concluded that uremia itself does not induce liver microsomal enzymes. The microsomal enzymes, however, remain inducible by foreign compounds even under uremic conditions.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 99598

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  11 in total

1.  Downregulation of hepatic acetylation of drugs in chronic renal failure.

Authors:  Emilie Simard; Judith Naud; Josée Michaud; Francois A Leblond; Alain Bonnardeaux; Chantal Guillemette; Edith Sim; Vincent Pichette
Journal:  J Am Soc Nephrol       Date:  2008-04-16       Impact factor: 10.121

2.  Reduced hepatic synthesis of calcidiol in uremia.

Authors:  Josée Michaud; Judith Naud; Denis Ouimet; Christian Demers; Jean-Luc Petit; Francois A Leblond; Alain Bonnardeaux; Marielle Gascon-Barré; Vincent Pichette
Journal:  J Am Soc Nephrol       Date:  2010-07-01       Impact factor: 10.121

3.  Alterations of Hepatic Metabolism in Chronic Kidney Disease via D-box-binding Protein Aggravate the Renal Dysfunction.

Authors:  Kengo Hamamura; Naoya Matsunaga; Eriko Ikeda; Hideaki Kondo; Hisako Ikeyama; Kazutaka Tokushige; Kazufumi Itcho; Yoko Furuichi; Yuya Yoshida; Masaki Matsuda; Kaori Yasuda; Atsushi Doi; Yoshifumi Yokota; Toshiaki Amamoto; Hironori Aramaki; Yasuhiro Irino; Satoru Koyanagi; Shigehiro Ohdo
Journal:  J Biol Chem       Date:  2016-01-04       Impact factor: 5.157

4.  Assessment of liver ability to biotransformation of antipyrine in uraemic patients on regular peritoneal dialysis treatment.

Authors:  A Grzegorzewska; Z Lowicki; E Chmara; A Mrozikiewicz; K Baczyk
Journal:  Int Urol Nephrol       Date:  1989       Impact factor: 2.370

5.  Down-regulation of hepatic cytochrome p450 in chronic renal failure: role of uremic mediators.

Authors:  Carl Guévin; Josée Michaud; Judith Naud; Francois A Leblond; Vincent Pichette
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

6.  The pharmacokinetics of gamma-glutamyl-L-dopa in normal and anephric rats and rats with glycerol-induced acute renal failure.

Authors:  Y A Boateng; H E Barber; T M MacDonald; J C Petrie; M R Lee; P H Whiting
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

Review 7.  The effect of chronic renal failure on drug metabolism and transport.

Authors:  Albert W Dreisbach; Juan J L Lertora
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-08       Impact factor: 4.481

8.  Quinine pharmacokinetics in chronic haemodialysis patients.

Authors:  Louise Roy; Pierre Bannon; Jean-Pierre Villeneuve
Journal:  Br J Clin Pharmacol       Date:  2002-12       Impact factor: 4.335

9.  Pharmacokinetics of tenoxicam in patients with impaired renal function.

Authors:  F F Horber; T W Guentert; E Weidekamm; P Heizmann; C Descoeudres; F J Frey
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

10.  The kinetics of metamizol and its metabolites in critical-care patients with acute renal dysfunction.

Authors:  G Heinemeyer; H J Gramm; I Roots; R Dennhardt; W Simgen
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.